Lifeward (LFWD) Net Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -315.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,018.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 399.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | 7,618.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,618.00 |
| Dec 31, 2025 | 13,857.00 |
| Sep 30, 2025 | 56,508.00 |
| Jun 30, 2025 | 16,854.00 |
| Mar 31, 2025 | 40,055.00 |
| Dec 31, 2024 | 10,814.00 |
| Sep 30, 2024 | 8,532.00 |
| Jun 30, 2024 | 15,456.00 |
| Mar 31, 2024 | 11,388.00 |
| Dec 31, 2023 | 15,988.00 |
| Sep 30, 2023 | 27,554.00 |
| Jun 30, 2023 | -17,603.00 |
| Mar 31, 2023 | 15,396.00 |
| Dec 31, 2022 | 5,888.00 |
| Sep 30, 2022 | -34,162.00 |
| Jun 30, 2022 | 23,985.00 |
| Mar 31, 2022 | -24,357.00 |
| Dec 31, 2021 | 717.00 |
| Sep 30, 2021 | 14,468.00 |
| Jun 30, 2021 | 10,878.00 |
| Mar 31, 2021 | 16,802.00 |
| Dec 31, 2020 | 16,494.00 |
| Sep 30, 2020 | -10,906.00 |
| Jun 30, 2020 | 14,319.00 |
| Mar 31, 2020 | -24,916.00 |
| Dec 31, 2019 | 23,431.00 |
| Sep 30, 2019 | 29,108.00 |
| Jun 30, 2019 | 59,288.00 |
| Mar 31, 2019 | 8,285.00 |
| Dec 31, 2018 | 24,411.00 |
| Sep 30, 2018 | -82,918.00 |
| Jun 30, 2018 | -127,965.00 |
| Mar 31, 2018 | 49,789.00 |
| Dec 31, 2017 | -78,115.00 |
| Sep 30, 2017 | -80,974.00 |
| Jun 30, 2017 | -139,395.00 |
| Dec 31, 2016 | -161,770.00 |
| Sep 30, 2016 | -145,419.00 |